Business Context and Reporting Period
This Form 6-K filing by Alcon, Inc. (NYSE: ACL), a leading global eye care company, covers the month of January 2003. The report incorporates a news release issued on January 13, 2003, providing preliminary expectations for the fiscal year 2002. Alcon develops, manufactures, and markets pharmaceuticals, surgical equipment, devices, and contact lens care solutions.
Key Financial Metrics
- 2002 Global Sales Expectation: Approximately $3.01 billion.
- Year-Over-Year Sales Growth: Expected to be 9.5% compared to 2001.
- Organic Sales Growth: Approximately 10.0% excluding the impact of foreign exchange fluctuations.
- Earnings Outlook: Expected to exceed prior guidance for both the fourth quarter and the full year, adjusted for previously reported one-time items.
- Cash Flow, Margins, Debt, and Liquidity: The filing text does not provide specific values for these metrics.
Material Changes Versus Prior Period
The primary material change is the upward revision of the 2002 financial outlook. Management anticipates sales growth of 9.5% over 2001, with earnings surpassing previous guidance levels after adjusting for one-time items. The filing notes that foreign exchange fluctuations impacted the reported growth rate, with organic growth estimated at 10.0%.
Guidance, Outlook, and Risks
Upcoming Events:
- Board of Directors meeting: February 18, 2003, to approve audited 2002 results.
- Release of audited financial results: After market close on February 19, 2003.
- Conference call: February 20, 2003, at 8:00 AM Eastern Time to discuss 2002 performance and 2003 outlook.
- Delays or cost overruns in product development.
- Changes in third-party payer reimbursement procedures.
- Increased competition affecting financial condition.
- Currency exchange rate fluctuations.
- Pending or future litigation and potential settlements.
- Product recalls or withdrawals.
- Government regulation, legislation, and changes in tax laws.
- Supply and manufacturing disruptions.
Investor Verification Checklist
- Verify the final audited 2002 sales and earnings figures when released on February 19, 2003.
- Confirm the specific impact of foreign exchange rates on the reported 9.5% growth versus the 10.0% organic growth.
- Review the details of "previously reported one-time items" to understand the adjusted earnings baseline.
- Monitor the February 20 conference call for specific 2003 guidance and updates on litigation or regulatory risks.